A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's Disease
Clinical trial NCT00160706 · COMPLETED
Trial details
- NCT number
- NCT00160706
- Sponsor
- UCB Pharma SA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2012-05-01
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.